FDA Grants Fast Track Designation For Prevail's Parkinson's Treatment

FDA Grants Fast Track Designation For Prevail's Parkinson's Treatment

Submitted by admin on July 9, 2019 - 8:42am
Source: 
Yahoo/Benzinga
News Tags: 
Prevail Therapeutics
FDA
PR001
fast track
Headline: 
FDA Grants Fast Track Designation For Prevail's Parkinson's Treatment
snippet: 

Prevail Therapeutics (NASDAQ: PRVL) shares are trading higher after the company received FDA fast track designation for PR001 for the treatment of Parkinson's disease patients with a GBA1 mutation.

Do Not Allow Advertisers to Use My Personal information